Parkinson disease: Gene therapy for Parkinson disease shows promise in phase II trial
- PMID: 21487423
- DOI: 10.1038/nrneurol.2011.48
Parkinson disease: Gene therapy for Parkinson disease shows promise in phase II trial
Comment on
-
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.Lancet Neurol. 2011 Apr;10(4):309-19. doi: 10.1016/S1474-4422(11)70039-4. Lancet Neurol. 2011. PMID: 21419704 Clinical Trial.
References
-
- Lancet Neurol. 2011 Apr;10(4):309-19 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
